Efficacy of Leuprorelide acetate (Eligard®) in daily practice in Brazil: a retrospective study with depot formulations in patients with prostate cancer
Conclusion: To our knowledge, this is the largest assessment of real-world data on alternative schedules of leuprolide in a Brazilian population. Our study suggests that PSA levels can be effectively be reduced in most patients treated with monthly, quarterly, or semiannual injections of long-acting leuprolide acetate.
Source: International Braz J Urol - Category: Urology & Nephrology Source Type: research
More News: Brazil Health | Cancer | Cancer & Oncology | Hormones | Impotence | Prostate Cancer | Statistics | Study | Toxicology | Urology & Nephrology